We are live on ! Find out more
OCDX

Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX

Delisted

OCDX was delisted on the 26th of May, 2022.

Back to rankings

1 hedge funds and large institutions have $1K invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 166 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 170 → 1 (-169)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $4.38B → $1K (-$4.38B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 166

Holders
1
Holders Change
-169
Holders Change %
-99.41%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
166
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CG
Carlyle Group
District of Columbia
-$2.2B
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$364M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$206M
4
BlackRock
BlackRock
New York
-$160M
5
JP Morgan Chase
JP Morgan Chase
New York
-$159M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
126
Allianz Asset Management
Germany
– -$300K -16,078 Closed
HA
127
Havens Advisors
New York
– -$299K -16,000 Closed
WSTAM
128
Wilbanks Smith & Thomas Asset Management
Virginia
– -$278K -15,800 Closed
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
– -$281K -15,059 Closed
OAM
130
Oppenheimer Asset Management
New York
– -$269K -14,425 Closed
LCM
131
Laurion Capital Management
New York
– -$264K -14,158 Closed
Victory Capital Management
132
Victory Capital Management
Texas
– -$248K -14,072 Closed
VT
133
Vise Technologies
New York
– -$261K -13,976 Closed
Squarepoint
134
Squarepoint
New York
– -$255K -13,684 Closed
BC
135
Bridgefront Capital
Texas
– -$246K -13,196 Closed
SEI Investments
136
SEI Investments
Pennsylvania
– -$249K -12,651 Closed
State Board of Administration of Florida Retirement System
137
State Board of Administration of Florida Retirement System
Florida
– -$228K -12,220 Closed
RA
138
Rise Advisors
New York
– -$225K -12,039 Closed
Bank of Montreal
139
Bank of Montreal
Ontario, Canada
– -$207K -11,079 Closed
TI
140
Telemetry Investments
New York
– -$205K -11,000 Closed
BCM
141
Bayesian Capital Management
New York
– -$203K -10,900 Closed
PCM
142
PenderFund Capital Management
British Columbia, Canada
– -$247K -10,600 Closed
CIBC Asset Management
143
CIBC Asset Management
Ontario, Canada
– -$192K -10,280 Closed
CC
144
Centiva Capital
New York
– -$187K -10,000 Closed
AIP
145
Ameritas Investment Partners
Nebraska
– -$174K -9,309 Closed
MLICM
146
Metropolitan Life Insurance Company (MetLife)
New York
– -$149K -8,001 Closed
SG Americas Securities
147
SG Americas Securities
New York
– -$126K -6,751 Closed
State of Tennessee, Department of Treasury
148
State of Tennessee, Department of Treasury
Tennessee
– -$123K -6,614 Closed
SWM
149
Spire Wealth Management
Virginia
– -$88K -4,700 Closed
QT
150
Quantbot Technologies
New York
– -$72K -3,900 Closed
3 4 5
6
7

OCDX Hedge Fund Activity: Q2 2022 in Review

1 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q2 2022, worth a combined $1K — down 100% from $4.38B a quarter earlier.

Sellers outnumbered buyers: 166 funds closed out of OCDX and 0 opened new positions — a net loss of 166 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Carlyle Group, exiting entirely with an estimated $2.2B sold.

  • 1 institutional investor held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q2 2022, down from 170 in Q1 2022.
  • Funds reported $1K of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q2 2022 and 166 closed out, a net change of -166 holders.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q2 2022 was Carlyle Group, an estimated $2.2B sold.

Based on aggregated 13F filings for Q2 2022.